NH

NantHealth, Inc. [NH] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

NH Stock Summary

In the News

07:04 04 Mar 2024 NH

NantHealth, Inc. (NH) Q3 2022 Earnings Call Transcript

NantHealth, Inc. (NASDAQ:NH ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Robert Jaffe - Investor Relations Ron Louks - Chief Operating Officer Bob Petrou - Chief Financial Officer Conference Call Participants Robert Jaffe Welcome everyone and thank you for joining us today to discuss NantHealth's 2022 Third Quarter Financial Results. On the call today are Ron Louks, Chief Operating Officer; and Bob Petrou, our Chief Financial Officer.

04:50 04 Mar 2024 NH

NantHealth to Report 2022 Third-Quarter Financial Results and Host Conference Call on Thursday, November 3

MORRISVILLE, N.C.

06:45 04 Mar 2024 NH

NantHealth, Inc. (NH) Management on Q2 2022 Results - Earnings Call Transcript

NantHealth, Inc. (NASDAQ:NH ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Robert Jaffe - Investor Relations Ron Louks - Chief Operating Officer Bob Petrou - Chief Financial Officer Robert Jaffe Welcome, everyone, and thank you for joining us today to discuss NantHealth's 2022 second quarter financial results. On the call today are Ron Louks, Chief Operating Officer; and Bob Petrou, our Chief Financial Officer.

03:30 04 Mar 2024 NH

NantHealth's (NH) Management on Q1 2022 Results - Earnings Call Transcript

NantHealth, Inc. (NASDAQ:NH ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Robert Jaffe – Investor Relations Ron Louks – Chief Operating Officer Bob Petrou – Chief Financial Officer Conference Call Participants Robert Jaffe Welcome, everyone, and thank you for joining us today to discuss NantHealth's 2022 First Quarter Financial Results. On the call today are Ron Louks, Chief Operating Officer; and Bob Petrou, our Chief Financial Officer.

10:16 04 Mar 2024 NH

NantHealth, Inc. (NH) Q4 2021 Results - Earnings Call Transcript

NantHealth, Inc. (NH) Q4 2021 Results - Earnings Call Transcript

08:46 04 Mar 2024 NH

NantHealth, Inc. (NH) Reports Q4 Loss, Tops Revenue Estimates

NantHealth, Inc. (NH) delivered earnings and revenue surprises of -11.11% and 0.19%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

10:05 04 Mar 2024 NH

NantHealth, Inc. (NH) Reports Q3 Loss, Misses Revenue Estimates

NantHealth, Inc. (NH) delivered earnings and revenue surprises of -25.00% and -18.88%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

08:00 04 Mar 2024 NH

NantHealth's Chief Medical Officer to Educate on Advancing Equity in Cancer Care at the Oncology Clinical Pathways Congress 2021

EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that Dr. Tiffany Avery, Chief Medical Officer, was selected to present a continuing education session at the Oncology Clinical Pathways Congress 2021. Dr. Avery's session, titled Utilizing Pathways to Advance Equity in Cancer Care, will take place virtually on Friday, October 1, 2021, and cover how clinical p

10:50 04 Mar 2024 NH

NantHealth, Inc. (NH) Management on Q2 2021 Results - Earnings Call Transcript

NantHealth, Inc. (NH) Management on Q2 2021 Results - Earnings Call Transcript

08:32 04 Mar 2024 NH

NantHealth, Inc. (NH) Reports Q2 Loss, Lags Revenue Estimates

NantHealth, Inc. (NH) delivered earnings and revenue surprises of 20.00% and -5.35%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

NH Financial details

Company Rating
Neutral
Market Cap
10.4M
Income
-70.37M
Revenue
64.27M
Book val./share
-16.67
Cash/share
0.39
Dividend
-
Dividend %
-
Employees
365
Optionable
No
Shortable
Yes
Earnings
02 Aug 2023
P/E
-0.16
Forward P/E
-
PEG
-0.25
P/S
0.15
P/B
-0.04
P/C
-
P/FCF
-0.3
Quick Ratio
0.56
Current Ratio
0.64
Debt / Equity
-0.39
LT Debt / Equity
-0.01
-
-
EPS (TTM)
-8.19
EPS next Y
-
EPS next Q
-
EPS this Y
14.29%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-19.59%
Revenue last 5Y
-5.62%
Revenue Q/Q
-27.74%
EPS Q/Q
-55.95%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0.01%
Inst Trans
1%
ROA
-38%
ROE
30%
ROC
-0.39%
Gross Margin
59%
Oper. Margin
-75%
Profit Margin
-95%
Payout
-
Shs Outstand
7.7M
Shs Float
2.02M
-
-
-
-
Target Price
-
52W Range
0.8505-9.749999
52W High
-
52W Low
-
RSI
-
Rel Volume
4.22
Avg Volume
50.67K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
1.82442
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

NH Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
12.2913.039.898.238.7
Net income per share
-26.17-8.51-11.96-7.7-8.8
Operating cash flow per share
-4.07-1.19-2.28-3.64-4.19
Free cash flow per share
-5.52-1.81-3.05-4.31-5.03
Cash per share
2.520.713.083.820.23
Book value per share
0.39-7.76-15.11-21.29-29.26
Tangible book value per share
-24.43-30.54-34.84-39.34-45.94
Share holders equity per share
0.39-7.76-15.11-21.29-29.26
Interest debt per share
29.931.9732.4935.6236.55
Market cap
59.41M113.78M358.38M120.43M28.12M
Enterprise value
241.58M325.97M556.69M347.91M293.76M
P/E ratio
-0.31-1.82-4.05-2.06-0.41
Price to sales ratio
0.661.194.91.920.42
POCF ratio
-2-12.98-21.26-4.35-0.87
PFCF ratio
-1.48-8.52-15.91-3.67-0.73
P/B Ratio
20.99-1.99-3.21-0.74-0.12
PTB ratio
20.99-1.99-3.21-0.74-0.12
EV to sales
2.73.47.615.554.38
Enterprise value over EBITDA
-1.4-8.93-8.65-8.69-7.73
EV to operating cash flow
-8.15-37.19-33.03-12.56-9.1
EV to free cash flow
-6.01-24.41-24.71-10.62-7.58
Earnings yield
-3.21-0.55-0.25-0.49-2.41
Free cash flow yield
-0.68-0.12-0.06-0.27-1.38
Debt to equity
70.81-3.81-1.98-1.58-1.19
Debt to assets
0.70.821.11.31.68
Net debt to EBITDA
-1.05-5.81-3.08-5.68-6.99
Current ratio
1.080.660.251.410.35
Interest coverage
-2.96-1.48-1.33-2.82-3.64
Income quality
0.150.140.30.470.48
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
0.230.20.240.310.34
Intangibles to total assets
0.630.630.730.690.81
Capex to operating cash flow
0.360.520.340.180.2
Capex to revenue
-0.12-0.05-0.08-0.08-0.1
Capex to depreciation
-0.47-0.21-0.34-0.32-0.4
Stock based compensation to revenue
0.060.030.040.060.07
Graham number
15.1338.5363.7660.7176.11
ROIC
-0.24-0.16-0.22-0.41-1.06
Return on tangible assets
-1.8-0.63-1.64-0.97-2.18
Graham Net
-34.73-41.98-38.62-42.84-48.82
Working capital
2.91M-19.59M-94.16M11.47M-23.05M
Tangible asset value
-177.8M-224.91M-257.7M-299.36M-353.84M
Net current asset value
-244.06M-285.71M-281.09M-320.41M-372.36M
Invested capital
70.81-3.81-1.98-1.58-1.19
Average receivables
14.18M14.02M8.02M5.31M7M
Average payables
2.41M2.8M4.54M4.16M6.81M
Average inventory
667.5K647K399K01.38M
Days sales outstanding
66.4744.6621.4736.841.8
Days payables outstanding
13.637.5363.9742.06131.73
Days of inventory on hand
4.097.580034.86
Receivables turnover
5.498.17179.928.73
Payables turnover
26.839.725.718.682.77
Inventory turnover
89.2548.150010.47
ROE
-67.271.10.790.360.3
Capex per share
-1.45-0.62-0.77-0.67-0.84

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
2.162.272.212.240.83
Net income per share
-1.77-3.33-1.59-2.27-1
Operating cash flow per share
-0.65-0.91-0.8500
Free cash flow per share
-0.82-1.22-1.0200
Cash per share
0.080.231.840.80.39
Book value per share
-26.11-29.26-30.72-32.87-16.67
Tangible book value per share
-43.08-45.94-47.25-49.26-24.89
Share holders equity per share
-26.11-29.26-30.72-32.87-16.67
Interest debt per share
33.8635.1937.8612.186.23
Market cap
28.46M28.12M15.41M10.4M20.26M
Enterprise value
285.18M293.76M288.74M102.82M112.77M
P/E ratio
-0.52-0.27-0.31-0.15-0.34
Price to sales ratio
1.711.610.90.61.63
POCF ratio
-5.66-3.99-2.3400
PFCF ratio
-4.5-3-1.9700
P/B Ratio
-0.14-0.12-0.07-0.04-0.08
PTB ratio
-0.14-0.12-0.07-0.04-0.08
EV to sales
17.1516.7916.935.969.04
Enterprise value over EBITDA
-46.44-16.15-56.98-11.78-10.73
EV to operating cash flow
-56.76-41.69-43.9300
EV to free cash flow
-45.13-31.38-36.8500
Earnings yield
-0.48-0.91-0.79-1.68-0.74
Free cash flow yield
-0.22-0.33-0.5100
Debt to equity
-1.28-1.19-1.21-0.39-0.39
Debt to assets
1.61.681.70.630.67
Net debt to EBITDA
-41.8-14.6-53.94-10.59-8.8
Current ratio
0.360.350.640.250.08
Interest coverage
-4.03-3.52-2.941.822.16
Income quality
0.370.270.5400
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
0.380.30.30.390.19
Intangibles to total assets
0.810.810.750.80.84
Capex to operating cash flow
0.260.330.1900
Capex to revenue
-0.08-0.13-0.0700
Capex to depreciation
-0.32-0.57-0.4300
Stock based compensation to revenue
0.050.060.0500
Graham number
32.2746.8333.1440.9719.35
ROIC
-0.23-0.27-0.220.060.07
Return on tangible assets
-0.45-0.82-0.29-0.56-0.65
Graham Net
-45.98-48.82-49.99-51.88-25.81
Working capital
-21.44M-23.05M-13.67M-44.23M-175.76M
Tangible asset value
-331.84M-353.84M-364M-379.5M-373.64M
Net current asset value
-349.93M-372.36M-381.43M-395.66M-381.32M
Invested capital
-1.28-1.19-1.21-0.39-0.39
Average receivables
6.28M7.35M7.44M6.85M5.53M
Average payables
5.53M8.31M10.09M7.98M6.44M
Average inventory
3.62M3.38M2.88M1.5M0
Days sales outstanding
38.0139.4738.0533.8733.03
Days payables outstanding
80.75126.84136.7497.82110.98
Days of inventory on hand
52.0533.5642.0700
Receivables turnover
2.372.282.372.662.72
Payables turnover
1.110.710.660.920.81
Inventory turnover
1.732.682.1400
ROE
0.070.110.050.070.06
Capex per share
-0.17-0.3-0.1600

NH Frequently Asked Questions

What is NantHealth, Inc. stock symbol ?

NantHealth, Inc. is a US stock , located in Morrisville of Nc and trading under the symbol NH

What is NantHealth, Inc. stock quote today ?

NantHealth, Inc. stock price is $- today.

Is NantHealth, Inc. stock public?

Yes, NantHealth, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Similar Market Cap